TRACON Pharmaceuticals Downgraded to Hold at StockNews.com - Defense World

TCONDelisted Stock  USD 1.60  0.55  52.38%   
About 55% of TRACON Pharmaceuticals' investors are presently thinking to get in. The analysis of overall sentiment of trading TRACON Pharmaceuticals stock suggests that some investors are interested at this time. TRACON Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in TRACON Pharmaceuticals. Many technical investors use TRACON Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
TRACON Pharmaceuticals Downgraded to Hold at StockNews.com Defense World

Read at news.google.com
Google News at Macroaxis
  

TRACON Pharmaceuticals Fundamental Analysis

We analyze TRACON Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TRACON Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TRACON Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

TRACON Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

TRACON Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with TRACON Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of TRACON Pharmaceuticals could also be used in its relative valuation, which is a method of valuing TRACON Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

TRACON Pharmaceuticals Related Equities

ANTXAN2 Therapeutics   21.90   
0%
100.0%
MNPRMonopar Therapeutics   8.84   
0%
40.0%
ACXPAcurx Pharmaceuticals   8.70   
0%
39.0%
VINCVincerx Pharma   7.69   
0%
35.0%
IKTInhibikase Therapeutics   6.96   
0%
31.0%
CYCNCyclerion Therapeutics   1.85   
0%
8.0%
PMVPPmv Pharmaceuticals   1.25   
0%
5.0%
ADXNAddex Therapeutics   1.04   
0%
4.0%
RZLTRezolute   1.00   
0%
4.0%
ACHLAchilles Therapeutics   0.93   
0%
4.0%
XOMAXOMA Corp   0.84   
0%
3.0%
ANEBAnebulo Pharmaceuticals   0.70   
0%
3.0%
TPSTTempest Therapeutics   1.04   
4.0%
0%
KRONKronos Bio   1.04   
4.0%
0%
ENTXEntera Bio   3.53   
16.0%
0%
LRMRLarimar Therapeutics   4.67   
21.0%
0%
CADLCandel Therapeutics   4.85   
22.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Consideration for investing in TRACON Stock

If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Valuation
Check real value of public entities based on technical and fundamental data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stocks Directory
Find actively traded stocks across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA